Nanobubble based sonobiopsy reveals circulating protein signatures of BBB opening and glioblastoma
Roni GattegnoiD, Divsha Sher, Or Zohar, Keren Moskov, Dinorah Friedmann-Morvinski, Tali IlovitshiD
Abstract
Focused ultrasound (FUS) and microbubbles can transiently increase blood brain barrier (BBB) permeability, yet verification of BBB opening (BBBO) relies mainly on contrast-enhanced MRI, offering limited insight into the molecular consequences of barrier modulation. Sonobiopsy, which uses FUS induced BBBO to release brain derived molecules into the bloodstream, provides a molecular readout from blood samples. Nanobubbles (NBs) are smaller agents that circulate more effectively in the brain microvasculature and have shown enhanced BBBO in capillaries. Here, NB-mediated proteomic sonobiopsy is used to improve biomarker efflux and increase molecular sensitivity, with the goal of defining the molecular signature produced by BBBO in healthy and glioblastoma (GBM) models, and distinguishing biomarkers associated with tumor pathology from BBBO biomarkers. Plasma collected before and after NB-mediated FUS underwent data-independent acquisition-based mass spectrometry, revealing post-BBBO changes in healthy and tumor bearing mice. In healthy cohorts, 77 proteins were reproducibly altered after BBBO. Six proteins (Dpysl3, Myl1, Mybpc1, Vsig4, Krt33a, Krtap6-5) were detectable only after BBBO in healthy mice. In 005 glioma bearing mice, the BBBO signature identified in healthy animals was preserved, and comparison with matched shams isolated tumor specific effects. Three proteins, Itih4, Lrg1, and Hp, rose significantly after BBBO only in GBM and reached higher post treatment levels than in shams, nominating candidate GBM-associated markers accessible via blood. These findings establish NB-mediated proteomic sonobiopsy as a promising method for BBBO verification and for detecting GBM associated protein signals, supporting the development of scalable BBBO confirmation and protein-based diagnostics in neuro oncology. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=92 SRC="FIGDIR/small/692317v1_ufig1.gif" ALT="Figure 1"> View larger version (27K): org.highwire.dtl.DTLVardef@d0186aorg.highwire.dtl.DTLVardef@1f2fe8borg.highwire.dtl.DTLVardef@25921forg.highwire.dtl.DTLVardef@9c3566_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ultrasound-Triggered Chemotherapy Extends Survival in a Genetically Engineered Glioblastoma Model
Joshua Antonio Whiting, Audri Dara, … Jan Kubanek·bioRxiv·Jul 3, 2026
- Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma
Maya Shumer-Elbaz, Nitay Ad‐El, … Tali Ilovitsh·Journal of Controlled ReleasePeer-reviewed·Jul 7, 2025
- MRI-Guided Focused Ultrasound Blood-Brain Barrier Opening Increases Drug Delivery and Efficacy in a Diffuse Midline Glioma Mouse Model
P. J. Martinez, G. Nault, … M. A. Borden·bioRxiv·Apr 5, 2023
- Data-driven feedback augments ultrasound nanotheranostics in brain tumors
Hohyun Lee, Victor Menezes, … Costas Arvanitis·bioRxiv·May 1, 2025
- Response of Serum-isolated Extracellular Vesicles to Focused Ultrasound Blood-Brain Barrier Opening
Alina R. Kline-Schoder, Fotios N. Tsitsos, … Elisa E. Konofagou·Ultrasound in Medicine & BiologyPeer-reviewed·Dec 20, 2024
- Neurobehavioral effects of focused ultrasound-mediated blood-brain barrier opening
Sophie K. Elvig, Alexandra A. Seas, … Steffen B. E. Wolff·bioRxiv·Aug 21, 2026